Last reviewed · How we verify

NCT03770221

Coordinating Access to Care for People Experiencing Homelessness (CATCH-FI)

Completed NA Last updated 18 May 2022
What this trial tests

NA trial testing CATCH in Mental Health Disorder in 176 participants. Completed in 31 May 2021.

Timeline
19 November 2018
Primary endpoint
31 May 2021
31 May 2021

Quick facts

Lead sponsorUnity Health Toronto
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment176
Start date19 November 2018
Primary completion31 May 2021
Estimated completion31 May 2021
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Unity Health Toronto — full company profile →

Who can join

18 and older, any sex, with Mental Health Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Coordinating Access to Care for the Homeless (CATCH) initiative is a multidisciplinary brief intervention for homeless adults with mental health needs discharged from hospital in Toronto, Canada. The study aims to evaluate the effect of financial incentives in facilitating treatment engagement of homeless people with mental illness, as well as in improving health, health service use and housing outcomes, compared to usual CATCH care, over 6 months, a critical time of transition from hospital to community care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Mental Health Disorder

Currently open trials in the same condition.

Other Unity Health Toronto trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03770221.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing